We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A payment approach that has the potential to drive greater collaboration between all services within an urgent and emergency care network.
How to use a crossover randomised controlled trial to evaluate your digital health product.
Guidance on referring alcohol dependent patients from hospital to specialist alcohol treatment in the hospital or in the community.
Guidance primarily aimed at local responders covering some humanitarian issues that may arise during the recovery phase of an emergency in the UK.
A toolkit designed to share experience and insights for developing shared outcomes across the health and care system.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Clarification for the interpretation of the new elements within the Veterinary Medicines Regulations (VMRs), as amended, relating to combating antimicrobial resistance (AMR).
How offender healthcare is managed in prisons and in the community.
Tax and reporting rules for employers providing medical or dental treatment and insurance
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
The CMA acts to help NHS patients access combination therapies used to treat serious medical conditions.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Principles to support decision making for those involved in safely planning and protecting visiting during outbreaks of infectious illness in adult social care.
How to account for VAT on goods and services provided by registered health professionals, including doctors, dentists, nurses and pharmacists.
Capitation is an example of a potential new payment model to enable integrated care.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).